Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 78
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05454098 | Clifutinib Food Effect Study in Healthy Subjects | ||
| NCT03638076 | The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules | ||
| NCT07102251 | A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects | ||
| NCT03487107 | Phase 3 Study of Yimitasvir Phosphate Capsules | ||
| NCT03655873 | The Study of a Selective 5-ht6 Receptor Antagonist, HEC30654AcOH,in Healthy Subjects | ||
| NCT03662568 | A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects | ||
| NCT05383131 | To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers | ||
| NCT04147208 | Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection | ||
| NCT04546984 | Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult Subjects | ||
| NCT04536532 | Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study | ||
| NCT04202952 | The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects | ||
| NCT03758287 | Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative | ||
| NCT04512170 | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects | ||
| NCT05497674 | Effects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy Subjects | ||
| NCT04827069 | A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML) | ||
| NCT05468346 | Study on the Body Mass Balance and Biotransformation of [14C]-HEC585 | ||
| NCT04925674 | Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis. | ||
| NCT03458481 | Phase 2 Study of Yimitasvir Phosphate Capsules | ||
| NCT05446233 | ADME Study of [14C] Antaitavir Hasophate in Healthy Male Subjects | ||
| NCT04565171 | Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD | ||
| NCT04625361 | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult Subjects | ||
| NCT05133882 | A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML | ||
| NCT05492630 | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects | ||
| NCT03811678 | The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects | ||
| NCT05374343 | A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Rongliflozin in Type 2 Diabetic Subjects With Renal Impairment | ||
| NCT05427682 | A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Pyroglutamate Rongliflozin Capsules in Subjects With Mild and Moderate Liver Damage | ||
| NCT03876925 | A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCC | ||
| NCT07099118 | A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects | ||
| NCT04865458 | A Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refractory B-cell Hematologic Malignancies | ||
| NCT04551261 | GLS4/RTV and TAF Drug-drug Interaction | ||
| NCT07211165 | Clinical Study on the Mass Balance of Clifutinib | ||
| NCT03462173 | The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects | ||
| NCT04415853 | Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer | ||
| NCT04422496 | The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects | ||
| NCT03663686 | The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects | ||
| NCT04324372 | Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors | ||
| NCT03903081 | The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects | ||
| NCT05802862 | A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China | ||
| NCT04601610 | KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma | ||
| NCT04194242 | The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects | ||
| NCT04232514 | Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects | ||
| NCT05459285 | A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects | ||
| NCT04992858 | Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations | ||
| NCT05397379 | A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis | ||
| NCT04201275 | The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects | ||
| NCT03092102 | The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects | ||
| NCT05139719 | A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients | ||
| NCT03502902 | The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects | ||
| NCT03943251 | The Study of a Selective Serotonin Partial Agonist and Reuptake Inhibitors, HEC113995PA•H2O,in Healthy Subjects | ||
| NCT03888092 | Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification |
